ReviewDiabetes care2026
The New Obesity Treatment Landscape: Challenges and Opportunities to Promote Shared Decision-Making in People With Obesity and Type 2 Diabetes.
Review in Diabetes care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The development and pilot testing of a shared decision-making encounter aid for weight management decisions.Obesity pillars · 2026Article
- Comment on Schumacher et al. Shared Decision-Making Feasibility Gap in Obesity and Type 2 Diabetes Care.Diabetes care · 2026Article
- Understanding obesity treatment choices: a mixed-methods study of patient preferences and shared decision-making.Translational behavioral medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
New obesity management guidelines, including those from the American Diabetes Association, advocate the use of shared decision-making (SDM) for obesity treatment. SDM is an evidence-based approach for promoting person-centered care and is widely recommended across medical specialties. However, a variety of issues challenge the use of SDM in daily practice. In this narrative review we discuss factors that may impede the use of SDM in adults with obesity and type 2 diabetes, as well as past efforts to address these barriers. Patient-level factors such as internalized weight bias and lack of knowledge about obesity and its treatment, provider-level factors such as limited training in obesity management and lack of confidence in sensitively discussing weight, and system-level factors like poor treatment access and limited care coordination stymie effective SDM around obesity management. A perceived power imbalance between patients and providers and medical mistrust are additional barriers for some. In the past, researchers have attempted to overcome these barriers to advancing SDM through approaches including patient decision aids, provider training, and clinical decision support systems, with moderate success. This article concludes with recommended strategies for clinical adoption of SDM for patients with obesity and type 2 diabetes, a call for system-level changes to create an environment more conducive to effective SDM, and directions for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.